Erin Huggins

409 total citations
13 papers, 110 citations indexed

About

Erin Huggins is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Erin Huggins has authored 13 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Erin Huggins's work include Lysosomal Storage Disorders Research (9 papers), Biochemical and Molecular Research (6 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Erin Huggins is often cited by papers focused on Lysosomal Storage Disorders Research (9 papers), Biochemical and Molecular Research (6 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Erin Huggins collaborates with scholars based in United States, Canada and Austria. Erin Huggins's co-authors include Priya S. Kishnani, Andrew P. Landstrom, Cheryl R. Greenberg, Harrison N. Jones, Laura E. Case, Kathryn Dahir, Ashlee R. Stiles, Manisha Balwani, Seung‐Hye Jung and Catherine Rehder and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Bone and Mineral Research and Bone.

In The Last Decade

Erin Huggins

13 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Huggins United States 6 49 41 40 36 19 13 110
Eszter Karg Hungary 4 71 1.4× 13 0.3× 29 0.7× 30 0.8× 14 0.7× 4 108
Dan Mellström Sweden 5 10 0.2× 68 1.7× 6 0.1× 40 1.1× 13 0.7× 5 155
Coromoto Palermo Puerto Rico 5 21 0.4× 42 1.0× 6 0.1× 39 1.1× 11 0.6× 10 122
Carlos Losilla Alcalde Spain 6 80 1.6× 28 0.7× 34 0.8× 52 1.4× 2 0.1× 31 152
Chwen-Keng Tsao Taiwan 5 24 0.5× 13 0.3× 9 0.2× 54 1.5× 12 0.6× 5 100
Javier Cámara Spain 5 48 1.0× 16 0.4× 17 0.4× 42 1.2× 31 1.6× 9 137
Mick Henderson United Kingdom 6 52 1.1× 12 0.3× 21 0.5× 100 2.8× 8 0.4× 6 175
Aránzazu Pintor‐Chocano Spain 4 30 0.6× 15 0.4× 25 0.6× 25 0.7× 9 0.5× 11 115
Ayako Matsunaga Japan 8 11 0.2× 9 0.2× 15 0.4× 200 5.6× 10 0.5× 16 238
Sekar Kanthimathi India 11 16 0.3× 70 1.7× 6 0.1× 98 2.7× 12 0.6× 22 284

Countries citing papers authored by Erin Huggins

Since Specialization
Citations

This map shows the geographic impact of Erin Huggins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Huggins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Huggins more than expected).

Fields of papers citing papers by Erin Huggins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Huggins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Huggins. The network helps show where Erin Huggins may publish in the future.

Co-authorship network of co-authors of Erin Huggins

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Huggins. A scholar is included among the top collaborators of Erin Huggins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Huggins. Erin Huggins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Rehder, Catherine, Gerald Webersinke, Cheryl R. Greenberg, et al.. (2025). Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. Journal of Bone and Mineral Research. 41(3). 259–269. 1 indexed citations
2.
3.
Kenney‐Jung, Daniel, et al.. (2024). Gaucher disease type 3c: Expanding the clinical spectrum of an ultra‐rare disease. JIMD Reports. 65(5). 313–322. 1 indexed citations
4.
Rehder, Catherine, Cheryl R. Greenberg, Kathryn Dahir, et al.. (2023). The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 178. 116947–116947. 26 indexed citations
5.
Jackson, David G., et al.. (2023). Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening. Molecular Genetics and Metabolism Reports. 36. 100989–100989. 2 indexed citations
7.
Diaz, Keith M., Erin Huggins, Marsha Michie, et al.. (2022). Recommendations to improve the patient experience and avoid bias when prenatal screening/testing. Disability and health journal. 16(2). 101401–101401. 13 indexed citations
8.
Huggins, Erin, et al.. (2022). Early clinical phenotype of late onset Pompe disease: Lessons learned from newborn screening. Molecular Genetics and Metabolism. 135(3). 179–185. 25 indexed citations
9.
Huggins, Erin, et al.. (2022). Early clinical phenotype of late-onset Pompe disease: Lessons learned from newborn screening. Molecular Genetics and Metabolism. 135(2). S57–S57. 1 indexed citations
10.
Jung, Seung‐Hye, et al.. (2022). Glucosylsphingosine (Lyso-Gb1): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease. International Journal of Molecular Sciences. 23(23). 14938–14938. 2 indexed citations
11.
Stiles, Ashlee R., et al.. (2021). The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher disease. Molecular Genetics and Metabolism Reports. 27. 100729–100729. 15 indexed citations
12.
Cohen, Jennifer L., Ankit K. Desai, Cindy Li, et al.. (2021). Early diagnosis and treatment of infantile-onset Pompe disease via newborn screen. Molecular Genetics and Metabolism. 132(2). S26–S27. 1 indexed citations
13.
Huggins, Erin, et al.. (2020). Multigenerational case examples of hypophosphatasia: Challenges in genetic counseling and disease management. Molecular Genetics and Metabolism Reports. 25. 100661–100661. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026